comparemela.com

Latest Breaking News On - Us lymphoma cart consortium - Page 1 : comparemela.com

Cellular Therapies in Lymphoma Bring Hope, but Optimizing Their Use Remains a Challenge

Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.

Barriers to CAR T-Cell Therapy for LBCL Challenge Physicians and Patients

CAR T-Cell Therapy Shown Safe, Effective in MCL With CNS Involvement

A small study suggests the use of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with mantle cell lymphoma (MCL) with secondary central nervous system (CNS) involvement is safe and effective.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.